Samirah Qureshi

Samirah Qureshi, MD, currently serves as Medical Director for Risk Management at Alexion Pharmaceuticals, Inc., specializing in Global Patient/Medical Safety within AstraZeneca Rare Disease since August 2020. Prior experience includes roles as Director and Global Head of Medical Review at AstraZeneca Rare Disease, Associate Medical Director at Biogen, and Pharmacovigilance Physician and Consultant at BIONPHARMA, INC. Additionally, Samirah Qureshi worked as a Clinical Research Scientist at Harvard Medical School and contributed to UNICEF on global health initiatives. Educational achievements include advanced degrees from Harvard Medical School, certifications in healthcare improvement from Harvard T.H. Chan School of Public Health, and a Bachelor of Medicine from Dow University of Health Sciences in Pakistan. Samirah Qureshi holds certifications in Postmarketing Drug Safety and Pharmacovigilance from the FDA.